2nd Quarter - Report — MCDERMOTT WILL & SCHULTE LLP for GENOMIC HEALTH INC (2009)

Firm

MCDERMOTT WILL & SCHULTE LLP

Client

GENOMIC HEALTH INC

Income

$400,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.

Lobbyist	Covered position, as disclosed
PAUL WILLIAM RADENSKY	—
SHEILA D WALCOFF	Committee, U.S. House of Representatives
ERIC ZIMMERMAN	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1699 (111th), S. 1220 (111th)

Medicare/Medicaid MMM

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.

Lobbyist	Covered position, as disclosed
PAUL WILLIAM RADENSKY	—
SHEILA D WALCOFF	Committee, U.S. House of Representatives
ERIC ZIMMERMAN	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1220 (111th), H.R. 1699 (111th)

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220..

Lobbyist	Covered position, as disclosed
PAUL WILLIAM RADENSKY	—
SHEILA D WALCOFF	Committee, U.S. House of Representatives
ERIC ZIMMERMAN	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: S. 1220 (111th), H.R. 1699 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.